Vizora日本語

Nippon ChemipharNIPPON CHEMIPHAR CO., LTD.4539東証スタンダード医薬品FY ending Mar 2026, consolidated, J-GAAP

Nippon Chemiphar FY ending Mar 2025 results

About 96% of Nippon Chemiphar's sales come from Medicine, with Other making up much of the rest.

Out of every ¥100 of sales, about ¥2 is left as operating profit.

Revenue changed +5.9% from the prior year, and it swung back to an operating profit.

Revenue and profit pattern

Turned profitable

What changed from last year

FY ending Mar 2024 → FY ending Mar 2025

Revenue
+5.9%¥30.7B → ¥32.6B
Gross profit
+13.0%¥7.74B → ¥8.75B
Operating income
Back to profit-¥494M → ¥606M
Net income attributable to owners
Back to profit-¥180M → ¥294M
Operating cash flow
-189.5%¥296M → -¥265M
Free cash flow
Loss-¥2.34B → -¥2.12B

Where the money goes

FY ending Mar 2024 → FY ending Mar 2025

Where ¥100 of sales goes

For every ¥100 Nippon Chemiphar sells, how much goes where, and how much is kept.

FY ending Mar 2025
Cost of sales
¥73
SG&A
¥25
Operating profit
¥2
Net profit kept
¥1

Annual margin trends

Gross margin26.9%
FY ending Mar 2020: 39.5%39.5%FY ending Mar 2021: 36.3%36.3%FY ending Mar 2022: 27.9%27.9%FY ending Mar 2023: 25.9%25.9%FY ending Mar 2024: 25.2%25.2%FY ending Mar 2025: 26.9%26.9%FY20FY21FY22FY23FY24FY25
Operating margin1.9%
FY ending Mar 2020: 1.1%1.1%FY ending Mar 2021: 1.8%1.8%FY ending Mar 2022: 2.5%2.5%FY ending Mar 2023: -0.8%-0.8%FY ending Mar 2024: -1.6%-1.6%FY ending Mar 2025: 1.9%1.9%FY20FY21FY22FY23FY24FY25
Net margin0.9%
FY ending Mar 2020: 1.4%1.4%FY ending Mar 2021: 1.6%1.6%FY ending Mar 2022: 2.2%2.2%FY ending Mar 2023: 1.1%1.1%FY ending Mar 2024: -0.6%-0.6%FY ending Mar 2025: 0.9%0.9%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2025

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第94期(2025/04/01－2026/03/31)

    ID S100YBOB2026-06-15Open

  • EDINET (FSA Japan)

    有価証券報告書－第93期(2024/04/01－2025/03/31)

    ID S100VWWK2025-06-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第92期(2023/04/01－2024/03/31)

    ID S100TNR22024-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第91期(2022/04/01－2023/03/31)

    ID S100R0RK2023-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第90期(令和3年4月1日－令和4年3月31日)

    ID S100OBPY2022-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第89期(令和2年4月1日－令和3年3月31日)

    ID S100LK702021-06-21Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image